1st Quarter - Report

AMERICAN PSYCHIATRIC ASSOCIATION for AMERICAN PSYCHIATRIC ASSOCIATION

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R 2124 / S.1148, the Resident Physician Shortage Reduction Act of 2015 S. 648, the Medicare Formulary Improvement Act of 2015 H.R. 2 Medicare Access and CHIP Reauthorization Act of 2015 H.R. 4277, Medical Mental Health Access Act CMS-3323-NC, Certification Frequency and Requirements for the Reporting of Quality Measures under CMS Programs Medicaid Program; Methods for Assuring Access to Covered Medicaid Services; Final Rule with Comment Period (CMS-2328-FC) and Medicaid Program; Request for Information - Data Metrics and Alternative Processes for Access to Care in the Medicaid Program (CMS-2328-NC)

LobbyistCovered position, as disclosed
SCOTT BARNES —
RODGER CURRIE —
DEANA M MCRAE —
VINCENT PACILEO —
JEFFREY P REGAN —
MATTHEW STURM —

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2 (114th), H.R. 4277 (114th), H.R. 2124 (114th), S. 648 (114th), S. 1148 (114th)

Budget/Appropriations BUD

S.1695, FY2016 Labor, Health and Human Services, and Education Appropriations Bill H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016

LobbyistCovered position, as disclosed
SCOTT BARNES —
RODGER CURRIE —
DEANA M MCRAE —
JEFFREY P REGAN —
MATTHEW STURM —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3020 (114th), S. 1695 (114th)

Medical/Disease Research/Clinical Labs MED

Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating Severe Major Depressive Episode in Patients 18 Years of Age and Older Who Are Treatment Resistant or Require a Rapid Response; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy for Certain Specified Intended Uses [Docket No. FDA-2014-N-1210] Electroconvulsive Therapy Devices for Class II Intended Uses: Draft Guidance for Industry, Clinicians, and FDA Staff; Availability [Docket No. FDA-2014-D-1318]

LobbyistCovered position, as disclosed
RODGER CURRIE —
MATTHEW STURM —

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Law Enforcement/Crime/Criminal Justice LAW

S. 524/H.R. 953, Comprehensive Addiction and Recovery Act of 2015 S. 707, Opioid Overdose Reduction Act S. 993/H.R. 1854, Comprehensive Justice and Mental Health Act H.R. 2872, the Opioid Addiction Treatment Modernization Act

LobbyistCovered position, as disclosed
SCOTT BARNES —
RODGER CURRIE —
DEANA M MCRAE —
VINCENT PACILEO —
JEFFREY P REGAN —
MATTHEW STURM —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2872 (114th), S. 524 (114th), H.R. 953 (114th), H.R. 1854 (114th), S. 993 (114th), S. 707 (114th)

Health Issues HCR

H.R. 6, 21st Century Cures Act H.R. 2646, Helping Families in Mental Health Crisis Act of 2015 S. 36, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 S. 524/H.R. 953, Comprehensive Addiction and Recovery Act of 2015 S. 707, Opioid Overdose Reduction Act S. 711, Mental Health First Aid Act S. 1893, Mental Health Awareness and Improvement Act S. 1945, Mental Health Reform Act of 2015 H.R. 1859, the Ensuring Childrens Access to Specialty Care Act H.R. 2690, the Including Families in Mental Health Recovery Act of 2015 H.R. 2872, the Opioid Addiction Treatment Modernization Act Docket No. CDC-2015-0112, Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain Dock No. HHS-OPHS-2015-0008, Federal Policy for the Protection of Human Subjects

LobbyistCovered position, as disclosed
SCOTT BARNES —
RODGER CURRIE —
DEANA M MCRAE —
NEVENA MINOR —
VINCENT PACILEO —
JEFFREY P REGAN —
MATTHEW STURM —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 711 (114th), S. 1893 (114th), H.R. 953 (114th), H.R. 2690 (114th), H.R. 2646 (114th), S. 1945 (114th), H.R. 2872 (114th), S. 524 (114th), S. 707 (114th), S. 36 (114th), H.R. 6 (114th), H.R. 1859 (114th)

Veterans VET

HR. 421 Classified Veterans Access to Care Act HR. 1331 Quicker Veterans Benefit Delivery Act S. 841 Prioritizing Veterans Access to Mental Health Care Act of 2015 HR. 1017 Veterans Information Security Act

LobbyistCovered position, as disclosed
SCOTT BARNES —
RODGER CURRIE —
DEANA M MCRAE —
JEFFREY P REGAN —
MATTHEW STURM —

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 1017 (114th), S. 841 (114th), H.R. 1331 (114th), H.R. 421 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.